Photocytotoxic Copper(II) Complexes with Schiff-Base Scaffolds for Photodynamic Therapy

Area of Science:

• Materials Chemistry
• Medicinal Chemistry
• Photochemistry

Background:

• Photodynamic therapy (PDT) requires photosensitizers with high phototoxicity for treating superficial diseases.
• Ideal photosensitizers are crucial for advancing PDT efficacy and minimally invasive treatment options.

Purpose of the Study:

• To synthesize and characterize novel copper(II) complexes as potential photosensitizers for PDT.
• To evaluate the phototoxicity and mechanism of action of these complexes against cancer cell lines.

Main Methods:

• Synthesis and structural confirmation of copper(II) complexes using mass spectrometry, FTIR, and X-ray crystallography.
• Determination of phototoxicity indices against human squamous cell carcinoma (SCC15) and basal cell carcinoma (BCC) cell lines.
• Investigation of mechanisms including reactive oxygen species generation, apoptosis, and caspase-3 activation.

Main Results:

• A series of copper(II) complexes, [Cu(^R QYMP)(dppn)], were successfully synthesized and characterized.
• Complex 4, [Cu(^3-OMe QYMP)(dppn)](ClO₄ ), exhibited high phototoxicity indices (329 for SCC15, 296 for BCC).
• The mechanism involves reactive oxygen species, apoptosis induction, and caspase-3 activation.

Conclusions:

• Copper complexes with Schiff-base ligands and dppn co-ligands show significant potential as photosensitizers for PDT.
• Complex 4 is a promising candidate for developing efficient metal-based anticancer agents for PDT applications.
• Further research into these copper complexes could lead to improved PDT strategies.